This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Likert score and Prostate Imaging Reporting And Data System (PI - RADS score) to assess the likelihood of prostate cancer based on multiparametric MRI

Authoring team

Two scoring systems are commonly used to evaluate the likelihood of prostate cancer on multiparametric MRI:

  • Prostate Imaging Reporting And Data System version 2 (PI-RADS_v2) which uses explicit criteria based on a zonal multiparametric MRI (mpMRI) dominant sequence (e.g. diffusion-weighted imaging in the peripheral zone (PZ) and T2 weighted imaging in the transition zone) to rate the suspicion of prostate cancer on a 5-point scale and

  • a subjective 5-point Likert assessment, based on each mpMRI sequence equally (unlike the use of dominant sequence in PIRADS_v2) and adapted to the radiologist's experience for overall impression

Both 5-point scales define the likelihood for the presence of prostate cancer, as follows

  • (1) highly unlikely,
  • (2) unlikely,
  • (3) equivocal,
  • (4) likely,
  • (5) highly likely

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.